Use of Transient Elastography in Assessment of Non Alcoholic Fatty Liver Disease

: The most prevalent chronic liver disease globally is non-alcoholic fatty liver disease (NAFLD). It is frequently regarded as the hepatic component of metabolic syndrome and is connected to obesity, T 2 DM and dyslipidemia. Among NAFLD patients there are 2 categories simple steatosis and non-alcoholic steatohepatitis (NASH), the later can lead to cirrhosis. The gold standard for identifying NASH and distinguishing it from simple steatosis is a liver biopsy, but it is intrusive and costy. New methods for evaluating NAFLD, the presence or absence of NASH and the severity of any comorbid fibrosis or cirrhosis must be developed. In this review, we'll demonstrate how to use transient elastography technique in FibroScan as a non-invasive tool (method) to identify patients with early disease from those progressed to fibrosis.

• Publication year

  2024

• Venue

  Sohag Medical Journal

• Publication date

  2024-01-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.21608/smj.2023.238958.1418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Ultrasound elastography in patients with fatty liver disease

  2020cited by this paper
• Current status of imaging in nonalcoholic fatty liver disease

  2018cited by this paper
• Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations.

  2018cited by this paper
• In search of new biomarkers for nonalcoholic fatty liver disease

  2016cited by this paper
• Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes

  2016cited by this paper
• Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

  2015cited by this paper
• Comparison between the M and XL probes for liver fibrosis assessment by transient elastography.

  2014cited by this paper
• Noninvasive assessment of liver steatosis using ultrasound methods.

  2014cited by this paper
• Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments

  2014cited by this paper
• The role of ultrasound elastographic techniques in chronic liver disease: current status and future perspectives.

  2014cited by this paper
• Determination of reliability criteria for liver stiffness evaluation by transient elastography

  2013cited by this paper
• Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD

  2013cited by this paper
• Non‐Invasive Methods to Determine the Severity of NAFLD and NASH

  2013cited by this paper
• Feasibility and reliability of the FibroScan S2 (pediatric) probe compared with the M probe for liver stiffness measurement in small adults with chronic liver disease.

  2013cited by this paper
• Levels of Alanine Aminotransferase Confound Use of Transient Elastography to Diagnose Fibrosis in Patients with Chronic HCV Infection

  2012cited by this paper
• The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

  2012cited by this paper
• Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

  2012cited by this paper
• Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease

  2012cited by this paper
• Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

  2012cited by this paper
• Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: a cross section study

  2011cited by this paper
• Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

  2011cited by this paper
• Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non‐alcoholic fatty liver disease patients

  2011cited by this paper
• Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.

  2011cited by this paper
• Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

  2010cited by this paper
• Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: the missing tool?

  2009cited by this paper
• Non-invasive evaluation of liver fibrosis using transient elastography.

  2008cited by this paper
• Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis

  2008cited by this paper
• Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency

  2008cited by this paper
• Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients.

  2007cited by this paper
• Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases

  2007cited by this paper
• AGA technical review on nonalcoholic fatty liver disease.

  2002cited by this paper
• Liver Involvement in Obese Children (Ultrasonography and Liver Enzyme Levels at Diagnosis and During Follow-up in an Italian Population)

  1997cited by this paper

• A comparative study of color Doppler ultrasonography and transient hepatic elastography (FibroScan) in grading non-alcoholic fatty liver disease patients and assessing hepatic hemodynamics

  2026cites this paper